The aim of this study was to assess the efficacy and safety of acupuncture therapy for patients with hypertension.
Background
Essential hypertension is a major risk factor for cardiovascular disease and stroke [1] . The number of adults with hypertension worldwide is predicted to reach 1.56 billion individuals by 2025 [2] . In China, hypertension affects more than one-fourth of the population. Moreover, the prevalence of hypertension has increased during recent decades and it has become a major health problem because treatment awareness and hypertension control rates are extremely low [3] .
The basic treatment for hypertension is non-pharmacological therapy, and includes weight loss, restricted sodium intake, physical activity, and cessation of smoking and alcohol consumption. However, long-term compliance with non-pharmacological treatment is difficult for most patients. Therefore, anti-hypertensive drugs are the preferred option for treating hypertension [4] . However, they are associated with adverse effects such as drug resistance. Therefore, more effective and safe treatment options are urgently required for hypertension patients.
Acupuncture treatment is an ancient Chinese therapy that has played an important role for over 2500 years in the Chinese healthcare system and has now been adopted worldwide. Several systematic reviews have evaluated the efficacy of acupuncture for hypertension [5] [6] [7] [8] [9] [10] [11] . Recently, some new trials have been published, leading us to conduct a systematic review and meta-analysis of all available randomized controlled trials (RCTs), to evaluate the efficacy and safety of acupuncture therapy for treating essential hypertension.
Material and Methods

Systematic review details
This systematic review was performed in accordance with the Cochrane Handbook for Systematic Reviews of Interventions, and was reported in compliance with the PRISMA statement (see Supplementary Table 1 for PRISMA checklist) [12] . This systematic review has been registered (Reg. No. CRD 42017068032) in PROSPERO (https://www.crd.york.ac.uk/prospero/) [13] .
Study search strategy
We systematically searched the PUBMED, EMBASE, the Cochrane Library, the Chinese Biomedical Literature Database (CBM), the Chinese National Knowledge Infrastructure (CNKI), and the Wan-fang databases for inclusion on 29 April 2017 with MeSH terms and key words, and without language restrictions. Search strategy terms were (acupuncture OR electroacupuncture OR acupoint) AND (high blood pressure OR hypertension OR blood pressure) AND (randomized controlled trial OR controlled clinical trial OR randomized OR clinical trials). We also checked the reference lists of relevant reviews and the included trials to identify further studies that met the inclusion criteria for this meta-analysis.
Inclusion criteria
Types of trials
We included randomized controlled trials (RCTs) and quasi-randomized controlled trials (quasi-RCTs) that were published in formal English or Chinese journals.
Types of participants
Based on the International Society of Hypertension Guidelines for the Management of Hypertension (1999 World Health Organization) [14] , essential hypertensive patients were those with a systolic blood pressure (SBP) ³140 mmHg and/or a diastolic blood pressure (DBP) of ³90 mmHg. All patients with secondary hypertension caused by an identifiable underlying primary cause were all excluded.
Types of interventions
Acupuncture therapy included acupuncture or electroacupuncture with or without lifestyle modifications and/or anti-hypertensive drugs. Control groups received sham acupuncture without any treatment or lifestyle modifications or anti-hypertensive drugs.
Types of outcome measures
Primary outcomes included SBP and DBP changes [pre-treatment BP -post-treatment BP]. Secondary outcomes included the efficacy rates and the adverse events. Efficacy rates were reported as the percentage of the total number of participants that showed reduction of DBP by ³10 mmHg, or normal DBP (£90 mmHg), or reduction of SBP by ³30 mmHg.
Data extraction
Two reviewers (HC and FES) screened all the literature and extracted data independently using a standardized form. The form was pre-designed for collecting information on trial characteristics, including first author, language, number of patients, mean age of the patients, diagnostic criteria, grades of hypertension, acupuncture treatment, control types, sessions of treatment, treatment course, and outcome measures. We defined the change values of blood pressure as pre-treatment BP minus post-treatment BP and extracted the change means and standard deviations (SD) for continuous outcome. For dichotomous 2947 outcome measures, we used rates (the number of events out of total number in the study). If change means and standard deviations were missing, we calculated them according to the formula offered by the Cochrane Handbook for Systematic Reviews of Interventions (Version 5.10) (see Supplementary  Figure 1 for formula). Disagreements were resolved in consultation with the third reviewer (YHG).
Assessment of the reporting quality of the included studies
Overall reporting quality score was evaluated for 30 parameters (items [1] [2] [3] [4] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] of the Consolidated Standards of Reporting Trials (CONSORT) [15] . The discussion section (items [20] [21] [22] was excluded because the items under this section could not be rated. We also excluded the section on other information (items 23-25) because they were not relevant for the methodology of the included studies. The Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA) includes 17 items that are substituted for item 5, 'interventions' in the CONSORT checklist [16] . Two reviewers (XDT and WBJ) assessed each item for the included studies independently.
Each reported item received 1 point, and any item not clearly presented received 0 points. Disagreements were resolved in consultation with the third reviewer (HC).
Risk of bias assessment
Two reviewers (XDT and WBJ) assessed the risk of bias of the included RCTs using the Cochrane Collaboration's tool for assessing risk of bias [17] . Each trial was scored as high, low, or unclear risk for the following 7 domains: (1) random sequence generation (selection bias); (2) allocation concealment (selection bias); (3) blinding of participants and personnel (performance bias); (4) blinding of outcome assessment (detection bias); (5) incomplete outcome data (attrition bias); (6) selective reporting (reporting bias); and (7) any other bias. Disagreements were resolved in consultation with the third reviewer (HC).
Statistical analysis
The overall reporting quality of the included studies and the potential differences between the studies from the Chinese journals and English journals were investigated in compliance Meta-analyses for acupuncture and electroacupuncture were done separately. Continuous data are presented as mean differences (MDs) with 95% confidence interval (CI) and data from studies were pooled using the inverse variance method. Dichotomous data are presented as relative risk (RR) with 95% CI and pooled using Mantel-Haenszel method. We also calculated the required information size based on the standard method [18, 19] . Statistical heterogeneity across trials was assessed by the Cochran Q test (P<0.1 for statistical significance) and quantified by the I 2 statistic. Following the Cochrane Handbook for Systematic Reviews of Interventions (Version 5.10), we defined I 2 >50% as indicating significant heterogeneity. Heterogeneous data were pooled using the random-effects model. We performed subgroup analysis based on the classes of anti-hypertensive drugs such as calcium channel blockers (CCB), b-receptor antagonists, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin receptor blockers (ARB). Moreover, in order to establish robust primary outcomes, we also performed sensitivity analysis for the primary outcomes. Publication bias was evaluated by visually inspecting a funnel plot. Meta-analysis was performed using RevMan 5.3 software. Figure 1 provides a flow chart summarizing the study selection process based on PRISMA guidelines. The initial search yielded 
Results
Study selection
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1146 records. After removing duplicate records, screening the titles and abstracts, and doing full text reviews, 30 trials were included in the meta-analysis .
Characteristics of the included studies
Characteristics of the included trials are summarized in Table 1 Mechanism used to implement the random allocation sequence (e.g., sequentially numbered containers) and description of any steps taken to conceal the sequence until interventions were assigned 4 (13) 0 (0) 4 (67)* Table 3 . CONSORT assessments of the reporting characteristics of the included studies (N=30; 24 studies from Chinese journals; 6 studies from English journals).
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Implementation 10 Individuals that generated the random allocation sequence, enrolled participants, and assigned participants to interventions
The group that was blinded after assignment to interventions (e.g. participants, care providers, those assessing outcomes) and the protocol of blinding, if performed
If relevant, description of the similarity of interventions
Statistical methods used to compare groups for primary and secondary outcomes 23 (77) 17 (71) 6 (100) 12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 3 (10)
The number of participants that were randomly assigned, received intended treatment, and were analyzed for the primary outcome are shown for each group
The number of participants that were lost or excluded after randomization and the reasons 2 (13) Results of any other analyses performed, such as subgroup and adjusted analyses; distinguishing pre-specified from exploratory analyses 
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effects. Twenty-eight of the 30 studies defined the criteria for hypertension as a systolic blood pressure (SBP) ³140mmHg or diastolic blood pressure (DBP) ³90 mmHg [22] [23] [24] [25] [26] [27] [28] [29] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] . Liu et al. [30] included hypertension patients with SBP ranging from 120-159 mmHg or DBP ranging from 80-99 mmHg. Yin et al. [49] included patients with SBP ranging from 120 to 180 mmHg or DBP 80 to 100 mmHg.
We analyzed the therapeutic outcomes of acupuncture or electroacupuncture with or without lifestyle modifications or anti-hypertensive drugs. The 5 most frequently used acu-points were LI11 (quchi; 18 studies), LR3 (taichong; 15 studies), GB20 (fengchi; 12 studies), ST36 (zusanli; 9 studies), and DU20 (baihui; 7 studies). Control groups included untreated patients and patients undergoing treatment by lifestyle modifications or anti-hypertensive drugs. The median course of the included studies was 28 days (range: 14-56).
Reporting quality of the included studies
We evaluated the reporting quality of the included studies according to CONSORT and STRICTA guidelines. The CONSORT median quality score was 10 (range: 4-29, Table 2 ), Based on the CONSORT, Chinese journals (median score: 10; range: 6-17) and English journals (median score: 9; range: 4-29) had similar reporting quality (P=0.875). However, consideration of individual items shows that the quality of English journals is better than Chinese journals for reporting items 1a, 2b, 8b, 9, 11a, 13b, 15, and 19 (all P<0.05; Table 3 ).
The STRICTA median score was 11 (range: 7-11, Table 2 ), and using STRICTA, English journals (median score: 12; range: 11-17) have a better reporting quality (P=0.03) than Chinese journals (median score: 11; range: 7-12). Similarly, the STRICTA report
shows that the quality of English journals is better than Chinese journals for items 1b, 1c, 4a, and 6a (all P<0.05; Table 4 ).
Risk of bias of the included studies
Most included studies had poor methodological quality because they lacked sufficient information to assess special items by the Cochrane risk of bias tool ( Figure 2 ). Two trials were quasi-RCTs [35, 45] , in which the patients were randomized according to even and odd numbers. Twenty-one trials generated a randomized sequence for patients by using a random number 
Acupuncture plus lifestyle modifications vs. lifestyle modifications
Three studies with 246 patients compared acupuncture plus lifestyle modifications and lifestyle modifications alone [34, 38, 49] . Two of the three studies (n=187) also reported the efficacy rate of acupuncture plus lifestyle medications and lifestyle modifications alone [34, 38] 
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This work is licensed under Creative Common AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) pressure [37] . SBP changes were greater in the combined therapy than with lotensin alone [SBP: MD=9.12 mmHg (95% CI: 3.96 to 14.28)]. However, DBP changes were similar in treatment groups [DBP: MD=4.46 mmHg (95% CI: -0.25 to 9.17)].
Study or subgroup
Subgroup analysis
Clinical heterogeneity is attributed in part to the use of different classes of anti-hypertensive drugs; drugs used included CCB, b-receptor antagonists, ACEI, and ARB. To control for this heterogeneity, we performed subgroup analyses of blood pressure for different classes of anti-hypertensive drugs. Pooled data indicated that DBP changes are similar in acupuncture and anti-hypertensive drug treatments (Figures 6, 7 ). One study [22] showed that acupuncture lowered SBP better than ARB 2961 reduced data were similar to the original results (Tables 5-7) , suggesting that the pooled data results are robust.
Safety evaluation
Nine of the included studies reported adverse events during the trial [22, [25] [26] [27] 29, 30, 38, 40, 41] . No study reported subject dropouts due to adverse events. In 4 studies [22, 26, 40, 41] , adverse events such as headache, syncope, dizziness, pain, cough, and bleeding were reported in the treatment group.
The adverse effects of headache, dizziness, cough, and hypotension were reported in the control group [22, 26, 40, 41] . The incidence of the adverse events was similar for both groups of patients [RR=0.48 (95% CI: 0.14 to 1.61), I
2 =52%].
Publication bias
A funnel plot analysis revealed strong asymmetry (Figure 8 ), suggesting potential publication bias, probably due to the small sample sizes of the included studies.
Discussion
This systematic review of 28 RCTs and 2 quasi-RCTs showed that acupuncture plus anti-hypertensive drug treatment was better than anti-hypertensive drugs alone or sham acupuncture plus anti-hypertensive drugs, based on change in SBP and DBP. These results suggest that acupuncture enhances the beneficial effects of anti-hypertensive drugs.
DBP changes were greater in patients treated with acupuncture than in untreated patients. Moreover, SBP changes were greater in patients treated with electro-acupuncture plus Lotensin than in Lotensin alone. However, since only 1 study was available to assess both of these comparisons [30] , these findings are preliminary and need further evidence.
Our findings also show that lowering of blood pressure is similar in treatments with acupuncture alone and with anti-hypertensive drugs alone. Blood pressure changes are similar for sham acupuncture and acupuncture treatments. Moreover, pooled data from 3 studies showed that blood pressure changes are similar for treatments with electro-acupuncture and anti-hypertensive drugs alone [32, 36, 42] . These results showed that acupuncture therapy alone was not sufficient for treating hypertension. However, there is significant heterogeneity among the studies; therefore, the quality of the results is low.
Subgroup analysis for different classes of anti-hypertensive drugs reveals that SBP changes are greater for acupuncture treatment than treatment with ARB and b-receptor antagonists. No significant differences are present in DBP changes between acupuncture and the different classes of anti-hypertensive drugs. However, the subgroup analysis reveals that acupuncture combined with CCB was more effective than CCB alone. These results are inconsistent and the data are insufficient to draw any conclusions.
We found that the reporting quality of the included studies was very low, especially for the Chinese journals. STRICTA statement analysis shows that the reporting quality of English journals is better than in Chinese journals. CONSORT statement 2962 analysis found no difference between the 2 groups overall, but the English journals had better reporting of the methodological section of the CONSORT statement (sequence generation, allocation, blinding, baseline data, and harms/adverse effects) than Chinese journals. Failure to report details of design methodology is a potential source of increased heterogeneity in the included studies. Therefore, these issues affected the analyses of acupuncture therapy for hypertension.
We also collected the published systematic reviews on the topic (Tables 8, 9 ). Compared with these systematic reviews, the current systematic review updates the latest evidence, and provides subgroup analysis based on the different classes of anti-hypertensive drugs, which generates most of the clinical heterogeneity. Nonetheless, several limitations to our metaanalysis exist. First, substantial heterogeneity exists among the included studies. In clinics, the methods of acupuncture and selection of the acu-points may vary because the treatment is based on the syndrome differentiation of Traditional Chinese Medicine, which leads to heterogeneity. Moreover, reporting quality of the included studies is low, especially in the methodology section of the study design, which can also be a source for heterogeneity. Second, a lack of translators meant we could only include Chinese and English studies, which leads to a selection bias. Third, sample sizes of the included studies, especially in Chinese trials, are small and the wide confidence intervals indicate high variability. Therefore, the precise effects of acupuncture therapy for treating hypertension remain uncertain given the high overall risk of bias in our included studies. Thus, well-designed and largesized RCTs are needed.
Conclusions
In conclusion, this review provides evidence that acupuncture enhances the therapeutic effects of anti-hypertensive drugs. However, the benefits and the safety of acupuncture therapy 2964 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. 
